Find Academic Supervisors

Kerry EmpeyView profile

Associate Professor

• Vaccine Development
• Immunology
• Clinical Translational Science
• +5 more

Kerry Empey is an Associate Professor in the Department of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. She serves as the Associate Dean of Graduate & Postdoctoral Programs and holds secondary appointments in the Department of Immunology, Center for Vaccine Research, and Clinical and Translational Science Institute (CTSI) in the School of Medicine. Her research focuses on optimizing vaccines and therapies for vulnerable populations, particularly infants and pregnant women, targeting respiratory syncytial virus (RSV) and other pulmonary pathogens. She directs the Certificate in Clinical Translational Science for health sciences graduate students. Education: PharmD from University of Rhode Island; PhD in Clinical Pharmaceutical Sciences from University of Kentucky; completed PGY1/PGY2 residencies in Pharmacy Practice and Infectious Diseases at University of Kentucky. Research Interests: Immune response modulation, vaccine adjuvant development, age-dependent immunity, pharmacokinetics/pharmacodynamics of monoclonal antibodies, and translational research in pediatric and maternal immunization strategies. Her work emphasizes vaccine safety and efficacy in infants, maternal immunization's protective effects, and understanding cytokine-mediated viral clearance mechanisms. Recent publications highlight advancements in RSV vaccine formulations, maternal immunization strategies, and immune mechanisms driving post-viral bacterial infections. Collaborative studies with vaccine experts and nanotechnology teams explore novel delivery systems for optimal immune responses.

Ting DuView profile

Assistant Professor

• Neuroscience
• Neurology
• Brain Fluid Homeostasis
• +7 more

Ting Du, M.D., Ph.D., is an Assistant Professor in the Department of Neurology at the University of Rochester Medical Center's School of Medicine and Dentistry. She leads the Du Lab, focusing on brain fluid homeostasis and its role in neurological diseases. Faculty: Assistant Professor, Department of Neurology Institution: University of Rochester Medical Center Lab: Du Lab Collaborations: Nedergaard Lab, Center for Translational Neuromedicine Research Interests: The Du Lab investigates cerebrospinal fluid (CSF) dynamics, glymphatic system function, and cervical lymphatic vessels in Alzheimer's disease, hydrocephalus, and traumatic brain injury. Key projects include: Restoring cervical lymphatic function to improve CSF drainage in aging Characterizing the subarachnoid lymphatic-like membrane (SLYM) in trauma Probing choroid plexus regulation in hydrocephalus Publication Trends: Recent work spans Neuroscience , Neurodegeneration , and Biophysics , with emphasis on: Glymphatic dysfunction in Alzheimer's Arterial pulsation-driven CSF flow Aquaporin-4's role in interstitial fluid Machine learning-based flow quantification Lab Affiliations: The Du Lab is part of the Neuroscience Ph.D. Program and Pathology - Cell Biology of Disease program, collaborating with experts in neuroimaging , fluid dynamics , and neurotherapeutics .

Greg AdamsonView profile

Assistant Clinical Professor

• Pediatric Cardiology
• Interventional Cardiology
• Pulmonary Arterial Hypertension
• +3 more

Greg Adamson is a Clinical Assistant Professor in the Department of Pediatrics - Cardiology at Stanford University School of Medicine and a member of the Maternal & Child Health Research Institute (MCHRI) . He specializes in Interventional Cardiology and Lymphatic Diseases , with clinical expertise in managing conditions like chylothorax and pulmonary arterial hypertension. Medical Education : St. Louis University School of Medicine (2014) Residency : University of California San Francisco (2017) Fellowship : Stanford University Pediatric Cardiology Fellowship (2020) Board Certifications : Pediatrics (2017) and Pediatric Cardiology (2024) Dr. Adamson's research focuses on pediatric pulmonary hypertension , cardiac catheterization protocols , and postoperative chylothorax management . His work includes developing prediction models for early chylothorax detection and evaluating vasopressin's hemodynamic effects in Fontan circulation patients. He has contributed to clinical practice guidelines for progressive pulmonary hypertension in children. His recent publications emphasize procedural efficiency in outpatient cardiac catheterization, valve repair durability in congenital heart disease, and standardized chylothorax algorithms . He utilizes multicenter collaborative frameworks and retrospective cohort analyses , with methodological approaches including logistic regression , Cox proportional hazards modeling , and consensus-building surveys . Key technical areas include lymphatic interventions , hemodynamic monitoring , and predictive analytics in pediatric cardiology. In clinical operations, he investigates same-day discharge criteria for pulmonary hypertension patients and optimal timing for advanced therapies . His work addresses practice variations in chylothorax treatment through quality improvement initiatives , including multidisciplinary algorithm development and ex vivo simulation testing for clinical implementation.

Barbara AndersenView profile

Professor

• Biobehavioral Oncology
• Psychological Interventions in Cancer Care
• Stress and Immune Function
• +3 more

Dr. Barbara Andersen is a Professor in Clinical Psychology at The Ohio State University (OSU), with a joint appointment in Obstetrics and Gynecology. She is affiliated with the College of Arts and Sciences and the Department of Psychology, where she has held leadership roles such as Director of the Behavioral Measurement Shared Resource. Her research focuses on biobehavioral aspects of cancer, particularly psychological interventions to improve quality of life and survival in patients with breast, lung, and hematologic cancers. Dr. Andersen has pioneered stress-reduction and cognitive-behavioral therapies for cancer patients, with her interventions widely disseminated in oncology settings. Education: PhD in Psychology (1980), MA (1978), and BS (1973) from the University of Illinois. She completed an internship at UCLA and joined OSU in 1989 after early career roles at the University of Iowa. Research interests include stress-immune interactions, depression in oncology patients, and functional resilience in advanced cancers. Key contributions include demonstrating the survival benefits of psychological interventions in breast cancer and identifying biomarkers linking mental health to cancer outcomes. Awards highlight her impact: University Distinguished Professor (2018), American Psychological Association’s Outstanding Contributions in Health Psychology (2003), and the Peter Minton Hero of Hope Medal (2004). She serves as President of the Society for Health Psychology (2021-2022). Teaching and mentorship: Developed OSU’s Health Psychology/Behavioral Medicine track, taught graduate courses, and mentored pre/postdoctoral trainees. Her labs focus on translational research in psycho-oncology and biobehavioral medicine.

Roger Dale KammView profile

Professor

• Microfluidics
• Cell mechanics
• Biological systems
• +6 more

Roger Dale Kamm is the Cecil and Ida Green Distinguished Professor at the Massachusetts Institute of Technology (MIT) in the departments of Mechanical Engineering and Biological Engineering . As a leading figure in mechanobiology, he directs the NSF Center on Emergent Behaviors of Integrated Cellular Systems and co-chairs the MIT faculty. His research focuses on microfluidic models for diseases such as metastatic cancer , Alzheimer’s , and ALS , with an emphasis on integrated cellular systems and living machines . His work bridges cell mechanics , biological systems , and vascular engineering , producing organ-on-a-chip and vascularized organoids for drug screening and disease modeling. Recent publications highlight innovations in neurovascular barriers , mechanical memory in cancer metastasis , and glymphatic system studies for neurodegenerative diseases. His lab develops 3D microfluidic platforms to simulate cardiovascular dynamics , neurological disease , and immune cell trafficking . Scientific Awards : National Academy of Engineering Fellow (2020) Shu Chien Achievement Award (2020) Nerem Medal (2018) Huiskes Medal (2015) Everett Moore Baker Award (2001) He has mentored numerous researchers and graduate students, including Ellen Kan and Marie Floryan . His Mechanobiology Lab at MIT pioneers microphysiological systems for vascular, neurological, and oncological applications, partnering with biotech/pharma for translational research.

Tracy HengView profile

Associate Professor

• Stem Cell Therapy
• Immunology
• Cell Therapy
• +3 more

Associate Professor Tracy Heng is an academic at Monash University, leading research on overcoming immunological barriers in stem cell therapies. She holds a PhD from Monash University and completed postdoctoral training at Harvard Medical School. Her roles include Laboratory Head in the Department of Anatomy & Developmental Biology and Deputy Head of the Immunity Program at the Monash Biomedicine Discovery Institute. Education: PhD, Monash University (strategies to improve immune function in ageing) Postdoctoral training with Professors Harald von Boehmer, Christophe Benoist, and Diane Mathis (Harvard Medical School, Immunological Genome Project) Research Interests: Understanding immune responses to stem cell transplantation, optimizing cell therapies, and addressing immunological challenges. Key areas include mesenchymal stromal cell apoptosis, lymphoid organ roles in therapy, and macrophage biology. Recent Articles: Focus on apoptosis-driven therapeutic mechanisms, stromal cell interactions with lymph nodes, and cytokine effects on cell survival. Recent work highlights the critical role of apoptosis in therapeutic efficacy and the importance of secondary lymphoid organs in cell therapy. Awards: 2015 Young Tall Poppy Science Award 2016 Metcalf Prize for Stem Cell Research 2016 NHMRC R.D. Wright Fellowship 2011 ARC Postdoctoral (Industry) Fellowship Projects: Leading projects such as 'The mesenchymal stromal cell paradox' (2022–2025) and 'Surface coatings for directed differentiation of iPSCs to T-cells' (2023–2026). Collaborates on initiatives like the ARC Training Centre for Cell and Tissue Engineering Technologies. Labs/Teams: Leads a research group focused on immunological barriers in stem cell therapies within the Monash Biomedicine Discovery Institute.

Emiel van der VorstView profile

Researcher

• Cardiovascular Research
• Atherosclerosis
• Immunology
• +6 more

Dr. Emiel van der Vorst is a cardiovascular researcher focusing on atherosclerosis, immunometabolism, and translational medicine . His work spans molecular mechanisms, therapeutic targeting, and omics-based approaches. Affiliation: Institute for Molecular Cardiovascular Research (IMCAR) Research Focus: Chemokine signaling, microRNA therapeutics, immune-metabolic interactions Research Trends: Recent publications highlight his exploration of microRNA-26b in metabolic liver disease GPR55 receptor in cardiomyocyte adaptation calcium-sensing receptor in sex-specific atherosclerosis aryl hydrocarbon receptor in gut-liver-cardiovascular axis His work integrates nanomedicine, genetic models, and clinical biomarker development .

Lauren M. HablitzView profile

Assistant Professor

• Circadian Rhythms
• Glymphatic System
• Neurodegenerative Diseases
• +3 more

Lauren M. Hablitz is an Assistant Professor in the Department of Neurology at the University of Rochester Medical Center , where she leads the Hablitz Lab at the Center for Translational Neuromedicine . Her research focuses on circadian synchrony , glymphatic system function , and chronotherapy in chronic neuropathic pain and stroke . Education: B.S. in Biology from Pennsylvania State University (2010) Ph.D. in Cell, Molecular, and Developmental Biology from University of Alabama at Birmingham (2015) Dr. Hablitz defined the endogenous circadian rhythm of the glymphatic system and discovered CSF distribution rhythms between brain and mandibular lymph nodes . Her work bridges circadian biology and neurovascular function , exploring how chronotherapy can improve outcomes in neurodegenerative diseases and pain disorders . Article trends show her team's focus on glymphatic system dysfunction in chronic pain models , Aquaporin-4 mechanisms , circadian disruption effects on neurovascular integrity , and peptidergic regulation via VIP/AVP signaling . Key technical approaches include in vivo imaging , confocal microscopy , and mass spectrometry . Scientific Awards: 2021 Outstanding Early Investigator Award 2020 Merit Award 2016 Tartar Trust Foundation Fellowship 2014 Trainee Award The Hablitz Lab collaborates with Dr. Maiken Nedergaard and includes Emma Waight (Technical Associate) and Eevalien Duyvesteyn (Research Assistant) . Projects span glymphatic dysfunction in chronic pain , circadian stroke rhythms , and lymphatic-glymphatic homology , using murine models and molecular manipulation .

Arnaud DidierlaurentView profile

Associate Professor

• Immunology
• Vaccinology
• Infectious Diseases
• +3 more

Prof. Arnaud Didierlaurent is an Associate Professor at the University of Geneva, specializing in immunology and vaccinology. His research focuses on adjuvant mechanisms, vaccine-induced immune responses, and age-related immune dynamics, with extensive work on SARS-CoV-2, influenza, and HIV vaccines. Institution: University of Geneva (unige.ch) Contact: E06.2750.A office, +4122 379 57 81 His scientific contributions include: Decoding AS01 adjuvant's age-independent activation of innate immunity Systems serology for adjuvant comparison in vaccine design Epigenetic monocyte reprogramming by vaccines Clinical evaluations of herpes zoster and Ebola vaccines Research trends from his 15 most recent publications show strong emphasis on: Vaccine adjuvant mechanisms (AS01, AS03, TLR agonists) Age-specific immune responses SARS-CoV-2 variant immunogenicity Neonatal vaccine development Autoinflammatory disease immunopathology

• Musculoskeletal Physiotherapy
• Ankle Instability
• Lower Limb Injuries
• +5 more

Dr. Marcos De Noronha serves as a Senior Lecturer in Physiotherapy at La Trobe University's Bendigo Campus within the La Trobe Rural Health School, where he has been employed since July 2012. His academic appointments and research activities are centered in the Physiotherapy department, focusing on evidence-based clinical practice and research in musculoskeletal conditions. His educational background includes: Bachelor of Physiotherapy from Federal University of São Carlos, São Carlos, Brazil (1994-1997) Certificate of Hydrotherapy from Universidade Tuiuti do Paraná, Curitiba, Brazil (1998-1999) Master of Human Movement Science from UDESC, Florianopolis, Brazil (2000-2001) PhD from University of Sydney, Sydney, Australia (2003-2007) Dr. De Noronha's research program demonstrates significant expertise in musculoskeletal physiotherapy, with particular focus on ankle instability, lower limb injuries, and knee osteoarthritis. His work often employs systematic review methodology, reflecting his commitment to evidence-based practice. He is also the co-author of a Cochrane Systematic Review on the effects of stretching on muscle soreness, highlighting his contribution to high-impact evidence synthesis in the field. His research extends to biomechanics, rehabilitation protocols, and clinical effectiveness of various physiotherapy interventions. Analysis of his recent publication record (2023-2025) reveals a strong emphasis on systematic reviews and clinical trials across multiple musculoskeletal conditions, particularly focusing on neck pain, knee osteoarthritis, and injury prevention. His work increasingly incorporates innovative methodologies including video-based assessment, telerehabilitation approaches, and quantitative sensory testing. The research demonstrates a clear trajectory toward understanding barriers to rehabilitation adherence, developing novel assessment tools, and examining the biomechanical aspects of common musculoskeletal conditions. Dr. De Noronha has been actively involved in research supervision, serving as joint supervisor for at least one research degree project titled 'The effects of sports specific fatigue in ankle joint, after a single leg drop jump in healthy participants' (2016-2018). He has secured external research funding from the Sao Paulo Research Foundation for a project examining 'The effects of different exercise protocols and different delivery methods on the progression of knee osteoarthritis' (2017-2018). His collaborative network is evident through his numerous co-authored publications across various institutions and countries, reflecting an active research program with multiple ongoing projects.

• Obesity Pathophysiology
• Diabetes Treatment
• Clinical Trials
• +5 more

Professor John Wilding is a leading academic in obesity and diabetes research at the University of Liverpool, where he has served as Professor of Medicine since 2005. He leads Clinical Research into Obesity, Diabetes and Endocrinology, directing specialist services for severe obesity at University Hospital Aintree – designated a Centre for Obesity Management by UK and European Associations. His leadership extends to chairing the NIHR Clinical Research Network Metabolic and Endocrine Speciality Group and contributing to NICE guidelines. His educational background includes graduation from Southampton University (1985), followed by clinical training and specialist diabetes/endocrinology training at London's Royal Postgraduate Medical School at Hammersmith Hospital, where he conducted three years of laboratory research on obesity neurobiology. Wilding's research focuses on developing novel treatments to reduce obesity-related disease burden , with expertise spanning: Clinical trials in obesity/diabetes (orlistat, sibutramine, GLP-1 analogues, SGLT2 inhibitors) Adipocyte biology and metabolism studies Functional neuroimaging of appetite regulation Autonomic nervous system assessment in metabolic disorders Non-invasive vascular measurements in insulin-resistant states His 15 most recent publications (2021-2025) reveal strong trends in GLP-1 receptor agonists (semaglutide, tirzepatide), obesity pharmacotherapy in special populations (elderly, non-diabetic), clinical guideline development , and economic burden analysis . Key themes include cardiovascular safety, real-world implementation of weight management services, and mechanistic studies of metabolic complications. Scientific recognition includes: Founding Fellow of International Obesity Taskforce (2004) Past Chair of UK Association for the Study of Obesity Immediate Past President of World Obesity Federation As an academic leader, Wilding has examined over 15 PhD/MD theses across UK institutions (Imperial College, Cambridge, Manchester), secured major grants from NIHR, MRC, and industry partners, and established Liverpool's first NHS-funded obesity service (now expanded regionally). His collaborative network spans neurology, cardiology, respiratory medicine, and psychology. Current major projects include PROGROUP (group obesity treatment), STRIVE (liraglutide in obesity services), and M3 Research Programme (early-onset type 2 diabetes). His research infrastructure includes a clinical investigation laboratory at Aintree Clinical Sciences Centre, featuring capabilities for hyperinsulinaemic euglycaemic clamps, indirect calorimetry, autonomic function testing, and body composition analysis – supporting both mechanistic studies and clinical trials.

Alayna E. LoiselleView profile

Professor

• Tendon Healing
• Musculoskeletal Biology
• Fibrosis
• +3 more

Alayna E. Loiselle, Ph.D., is a Professor in the Department of Orthopaedics and holds joint appointments in Biomedical Engineering and Pathology & Laboratory Medicine at the University of Rochester School of Medicine and Dentistry (SMD). She leads the Musculoskeletal and Soft Tissue Fibrosis and Regeneration Lab, focusing on tendon healing mechanisms, fibrosis, and aging-related degeneration. Her work integrates molecular, cellular, and biomechanical approaches to identify therapeutic targets for tendon injuries. Dr. Loiselle's research has been recognized with awards such as the 2022 Kappa Delta Young Investigator Award and the Goldner Pioneer Award (2014). Education includes a PhD from the University of Rochester School of Medicine & Dentistry (2009), a BS in Biology from Niagara University (2004), and postdoctoral training at Penn State College of Medicine (2013). Her lab investigates cellular lineages (e.g., Scleraxis/S100a4) driving fibrotic responses, age-related tendon dysfunction, and diabetes-induced healing impairments. Recent studies highlight macrophage-myofibroblast interactions and spatial transcriptomics in tendon healing. Key projects include tendon regeneration strategies, lifespan maintenance of tendon structure, and soft tissue fibrosis mechanisms. Dr. Loiselle advises graduate students like Katherine Best and Jess Ackerman, and collaborates with institutions like the Center for Musculoskeletal Research. Her lab actively seeks candidates for PhD and postdoctoral positions in musculoskeletal biology. Scientific contributions span over 50 peer-reviewed articles, including work on NF-κB signaling in tendon fibrosis and partial reprogramming to combat aging-related degeneration. Grants support investigations into biologic factors in tendon healing and translational therapies. Lab affiliations include the BME PhD Program and Cell Biology of Disease PhD Program at URMC.

Katerina TritsarisView profile

Associate Professor

• Angiogenesis
• Lymphangiogenesis
• Inflammation
• +5 more

Katerina Tritsaris is an Associate Professor at the Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, where she leads the Tritsaris Group within the Morphogenesis and Differentiation Program. Her research focuses on vascular biology, particularly angiogenesis, lymphangiogenesis, inflammation, interleukins, and cell signaling. She also serves as Deputy Head of Department for Education and administrator of the course "Medical cell and tissue biology." Her educational background includes: Ph.D. degree from University of Copenhagen (2001) Master degree in Biochemistry from University of Copenhagen (1995) Dr. Tritsaris's primary research investigates how small pulsed electromagnetic fields activate endothelial cells and neurons, the role of IL-27 in tumor angiogenesis and growth, the effects of glucagon-like peptide (GLP-1) on vessel wall integrity, and IL-27 regulation of angiogenesis in the retina. Her work bridges molecular mechanisms with physiological outcomes, particularly in vascular biology and inflammation. She has characterized how GLP-1 interacts with VEGFA-induced signaling pathways, identifying mechanisms by which GLP-1 can abolish VEGFA-induced vasodilation while maintaining vessel wall permeability. Analysis of her extensive publication record (43 research outputs) reveals a strong focus on vascular endothelial cell biology with particular attention to signaling pathways involving GLP-1, VEGF, and interleukins. Her research spans multiple physiological systems including cerebrospinal fluid production, inflammatory bowel disease, tumor microenvironment, and ischemic conditions. A notable trend is her integration of biophysical approaches (electromagnetic fields) with molecular signaling studies to understand vascular function. Scientific recognition includes: Landsforeningen til Bekæmpelse af Kredsløbssygdommes Legat Dr. Tritsaris actively supervises molecular biomedicine bachelor and master students and teaches medical, odontology, and molecular biomedicine undergraduate students in cell biology. Her research group maintains extensive collaborations with Queen's University Belfast, Karolinska Institute, and multiple departments at Copenhagen University Hospital, reflecting the translational nature of her work from basic science to potential clinical applications. The Tritsaris Group operates within the Morphogenesis and Differentiation Program at the University of Copenhagen, with ongoing projects exploring how GLP-1, which peaks after meal intake, might control vessel permeability for nutrients in specific blood circulation segments. Her research continues to make significant contributions to understanding the dynamics of vessel integrity and permeability in health and disease.

John Fleng SteffensenView profile

Professor

• Comparative respiratory physiology
• Circulatory physiology of fish
• Metabolic cold adaptation
• +8 more

John Fleng Steffensen is a Professor in the Department of Biology within the Faculty of Science at the University of Copenhagen, specializing in Marine Biology. With over 239 research outputs and extensive international collaborations, he maintains an active research program focused on fish physiology. His work spans multiple continents and has been featured in numerous high-profile media outlets including the New York Times, Wall Street Journal, and Le Monde. Dr. Steffensen earned his M.Sc. in Biology/Zoophysiology from Aarhus University in 1980 and completed his Ph.D. in the same field in 1984. Prior to his current position, he held postdoctoral positions at University of British Columbia (1985), Aarhus University (1986-1988), and served as a Visiting Scientist at University of Miami (1980-1981). His research primarily focuses on comparative respiratory and circulatory physiology of fish, examining metabolic cold adaptation in Arctic and Antarctic fish species, the benefits and challenges of fish schooling behavior, aquaculture growth improvements, environmental hypoxia and temperature adaptation, swimming metabolism and kinematics, and the form-function relationship of teleost circulatory systems. A significant portion of his recent work has centered on the biology, physiology, and extraordinary longevity of the Greenland shark, which culminated in major media coverage in 2024 regarding the mapping of its genome. Analysis of Dr. Steffensen's recent publications reveals a strong interdisciplinary approach combining physiology, biomechanics, and conservation biology. His work spans from fundamental physiological mechanisms to applied conservation questions, with particular emphasis on how fish respond to environmental stressors like warming oceans and hypoxia. The Greenland shark longevity research represents a major contribution to understanding extreme lifespan in vertebrates. American Fisheries Society, Physiology Section. Award of Excellence (2022) Dr. Steffensen has been actively involved in numerous research networks and collaborative projects, including the EU Cost Action FA1303 FitFish (2015-2018), TUNU-Programme on Marine Fishes of NE Greenland (2007-2015), and MADFISH (Molecular Adaptations of FISH). He has organized significant training courses including the FitFish Training Course in Respirometry and the MadFish Respiratory and Circulatory Fish Physiology PhD-course. His research has received considerable attention, with his 2016 Science paper on Greenland shark longevity accumulating over 245 citations and extensive media coverage. Dr. Steffensen maintains the Marine Biology Laboratory (MBL) at the University of Copenhagen, where his team conducts research on fish physiology using advanced respirometry systems and molecular techniques. His lab has been instrumental in developing methods for studying fish metabolism and has contributed significantly to our understanding of how fish adapt to extreme environments.

Douglas TilleyView profile

Professor

• Cardiovascular Sciences
• G protein-coupled receptors (GPCRs)
• Heart Failure
• +12 more

Douglas Tilley, PhD, is a Professor and Assistant Dean at the Lewis Katz School of Medicine at Temple University. He holds appointments in the Department of Cardiovascular Sciences and is affiliated with the Aging + Cardiovascular Discovery Center and the Lemole Center for Integrated Lymphatics and Vascular Research. His research focuses on GPCR signaling in cardiac and immune systems, particularly in the context of heart failure and post-injury remodeling. Dr. Tilley's research interests center on molecular mechanisms of cardiac dysfunction and immune regulation. His work investigates how G protein-coupled receptors such as β2-adrenergic receptors and EGFR regulate cardiac contractility, inflammation, and fibrotic remodeling. Key projects include understanding the dual roles of EGFR in hypertrophy and contractile homeostasis, the immunomodulatory effects of β2AR on leukocytes after cardiac injury, and the role of immune cells in cardiorenal syndrome progression. These studies aim to identify novel therapeutic targets for heart failure and related multi-organ pathologies. His research bridges pharmacology, immunology, and cardiovascular physiology. Though no publications are listed in the provided text, the described projects indicate a strong focus on signal transduction pathways, receptor crosstalk, and organ-system interactions in chronic disease. This work contributes to precision therapeutic strategies in cardiovascular medicine. American Society for Pharmacology and Experimental Therapeutics American Heart Association International Society for Heart Research, American Section Dr. Tilley mentors within a multidisciplinary research environment and leads projects supported by institutional and potentially external funding, though specific grants are not detailed. His role as Assistant Dean suggests leadership in academic programming or research administration. He is actively involved in advancing cardiovascular discovery through team-based science in integrated research centers. He is a key member of the Aging + Cardiovascular Discovery Center and the Lemole Center for Integrated Lymphatics and Vascular Research, where he collaborates on vascular biology, lymphatic function, and systemic inflammation in cardiovascular disease. These centers provide a collaborative platform for translational research aimed at improving outcomes in aging and chronic cardiovascular conditions.